Back to Miscellaneous News
Kilpatrick Townsend Expands Health & Life Sciences Practice
Thursday, August 21, 2014
Kilpatrick Townsend & Stockton announced today the addition of Andrew Serafini, Ph.D., to the firm's Seattle office. Dr. Serafini will be a Partner in the internationally recognized Intellectual Property Group's Health and Life Sciences Team.
"We welcome Andrew back to the firm," says Roger Wylie, Managing Partner of the Seattle Office. "He is a preeminent leader in Seattle's thriving Health & Life Sciences community. Andrew’s experience and background further strengthens the firm's well-respected and deep Life Sciences team and bolsters our presence in Seattle -- a top priority for the firm. With Andrew’s addition, the Seattle office can provide the full gamut of intellectual property disciplines to clients of all technologies.”
"I am looking forward to leading Kilpatrick Townsend's Health and Life Sciences sector in Seattle," says Andrew Serafini. "The firm's commitment to Life Sciences coupled with the firm’s continuing growth in US, Europe, and Asia is a perfect complement to my practice. Kilpatrick Townsend's international reach, rich multi-disciplinary experience and strong resources, will be of great benefit to our mutual clients."
Dr. Serafini, who is joining the firm from Fenwick & West, focuses his practice on representing biotechnology, biopharmaceutical, and other life sciences clients on intellectual property strategy and counseling. He has worked extensively on the strategic development of patent portfolios in numerous areas including immunology, molecular biology, antibody engineering and therapeutics, vaccines, stem cell technologies, molecular genetics, genomics, proteomics and protein chemistry, pharmaceuticals, medical therapeutics, nanotechnology, cleantech, medical diagnostics and personalized medicine. Early in Dr. Serafini’s career, he was an associate with the predecessor firm to Kilpatrick Townsend.
Dr. Serafini earned his J.D. from the University of California, Hastings College of the Law. He received his Ph.D. in Immunology from Stanford University School of Medicine and his B.S., with honors, in Biochemistry from the Case Institute of Technology of Case Western Reserve University. Dr. Serafini is an adjunct professor at the University of Washington School of Law and a mentor with their Entrepreneurial Law Clinic. He a member of the Seattle Trade Alliance Advisory Council and the China Policy Committee for the Washington Council on International Trade.
Dr. Serafini was named “Volunteer of the Year,” by the Washington Biotechnology & Biomedical Association (WBBA) in 2013 and has been recognized as a "Rising Star" in Intellectual Property category by Washington Super Lawyers for multiple years.
For more information about Kilpatrick Townsend, please visit: www.kilpatricktownsend.com.
Follow the firm on Twitter: @KTS_Law.
Back to Miscellaneous News